Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Suetonia C Palmer
Metformin as First-Line Treatment for Type 2 Diabetes
The Lancet
Medicine
HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis
Cochrane Database of Systematic Reviews
Related publications
Metformin Remains the Best Treatment for Type 2 Diabetes
BMJ
Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes
Scientific Reports
Multidisciplinary
Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Should Sodium Glucose Co-Transporter 2 Inhibitors Be Considered as First Line Oral Therapy for People With Type 2 Diabetes?
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Intensive Insulin Therapy as the Primary Treatment for Type 2 Diabetes
Clinical Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exploring Treatment Strategies for Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Metformin in Patients With Type 2 Diabetes and Kidney Disease
JAMA - Journal of the American Medical Association
Medicine
